Live stream preview
Antihyperglycemic Medications for Cardiovascular Risk Reduction (0.75)
Cardiology Grand Rounds 2022-23 (14.25 CME)
•
45m
Texas Heart Institute Cardiology Grand Rounds on February 3, 2023. Dr. Darren K. McGuire. Antihyperglycemic Medications for CV Risk Reduction: a cardiologist's perspective.
Tags
Up Next in Cardiology Grand Rounds 2022-23 (14.25 CME)
-
New Approaches to HFpEF in the Era of...
Texas Heart Institute Cardiology Grand Rounds on February 10, 2023. Dr. Sanjiv J. Shah. New Approaches to HFpEF in the Era of Precision Medicine
-
The Role of Titin in Heart Function a...
Texas Heart Institute Cardiology Grand Rounds on March 10, 2023. Dr. Henk L. Granzier. The Role of Titin in Heart Function and Disease
-
Fibromuscular Dysplasia: The Rare Dis...
The Texas Heart Institute Cardiology Grand Rounds on March 24, 2023. Dr. Jeffrey W. Olin. Fibromuscular Dysplasia: The Rare Disease That Isn't
